An Empirical Note on Comparative Perceptions of Indian Patients and Physicians in Direct-to-Consumer Promotion of Pharmaceutical Products

An Empirical Note on Comparative Perceptions of Indian Patients and Physicians in Direct-to-Consumer Promotion of Pharmaceutical Products

Jaya Rani Pandey (Sikkim Manipal University, India), Ajeya Jha (Sikkim Manipal University, India), Samrat Kumar Mukherjee (Sikkim Manipal University, India) and Saibal Kumar Saha (Sikkim Manipal University, India)
DOI: 10.4018/978-1-5225-7095-0.ch009

Abstract

Direct promotion of pharmaceutical products to patients is not legal in India. Internet healthcare websites, however, have rendered this law moot. Patients today increasingly flock to websites to find health-related information. With the help of a survey involving 400 patients and 200 physicians, this chapter attempts to identify the differences in the perception of physicians and patients. The results indicate that major differences exist in the beliefs held by physicians and patients vis-à-vis merits and demerits of DTC-promotion through health-related websites. As patients and physicians operate as a team while health-solutions are made available to the patients, such major differences in their beliefs regarding the merits and demerits of DTC-promotion may result in emergence of fault lines in their relationship. An exploratory factor analysis has been conducted to confirm if the underlying variables measure the latent factors or not. Regression model has been developed to measure the impact of information perception on patient-physician relationship.
Chapter Preview
Top

Review Of Literature

There is a great discussion that direct marketing of the prescription drugs can be both harmful as well as beneficial for the customers. Many studies have been conducted in this regard. At one side many researchers in USA consider it as a valuable source of information but there are many who argue that it is potentially harmful for the customers. Auton (2004) argue that DTC advertising enriches customers by providing information about health problems, treatment options and medical advances. Peytrotetal (1998)and O’Brien Anne (2008)found that branded DTC ads which clearly address the patient’s need are very few. He also argues that patients are more involved in DTC and are willing to discuss it with physicians. Robinson et.al (2004) stated that advertisement for a pharmaceutical product raises serious ethical concerns. They underrate risk, target the emotions of the patients and it is also adversely affecting the patient – physician relationship. Scott Ehrlich found that Caduet, Crestor and Lipitor were among the few that used an on-screen personality to deliver the risk information. Scott analyzed that a closer look at broadcast DTC ads reveals that marketers are taking very different approaches to presenting details on risks and benefits. Christopher M. Schroeder(2010) outlined that Consumers are taking charge of their healthcare like never before. They are doing more research before a doctor visit, more closely monitoring their doctor’s recommendations and consulting with friends and family to validate their decisions. Jha (2005) suggested that DTC is an important variable in pharmaceutical marketing in Indian perspective. Taking care of patients is necessary for better patient-physician relationship (PPR). Many factors included like interpersonal features, clinical care expectations, and aspects of communication (Kurlander et.al., 2017).

Complete Chapter List

Search this Book:
Reset